Héctor Guadalajara Labajo

21PUBLICATIONS
34CO-AUTHORS
Forest health and pathologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 13, 2026
Correction: Guadalajara et al. Impact on Clinical- and Patient-Reported Outcomes Measures of an Organ Preservation-Based Therapeutic Strategy in Locally Advanced Rectal Cancer: The FOREST Project. J. Clin. Med. 2026, 15, 844.

|Jul 29, 2026
SEPTIN9 Gene Methylation Ratio as Follow-Up Biomarker in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

|Jan 28, 2026
Impact on Clinical- and Patient-Reported Outcomes Measures of an Organ Preservation-Based Therapeutic Strategy in Locally Advanced Rectal Cancer: The FOREST Project.

Hector Guadalajara, Ion Cristóbal, Raquel Fuentes-Mateos

|Nov 24, 2025
Barbed versus conventional sutures and the risk of abdominal wall dehiscence after laparotomy: a multicenter retrospective cohort study.

Hector Guadalajara, Marius Kaser, Miguel León Arellano

|Sep 15, 2025
Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient-centered approach that clusters two cohorts with different outcomes.

Hector Guadalajara, Jose Luis Domínguez-Tristancho, Raquel Fuentes Mateo

|Apr 14, 2025
Inflammatory Fibroid Polyp (Vanek's Tumor): A Retrospective Multicentric Analysis of 67 Cases.

Mario Martín Sánchez, Víctor Domínguez-Prieto, Siyuan Qian Zhang

Pageof 4

Frequent Collaborators

16 joint publications

Damián Garcia-Olmo

7 joint publications

Miguel León-Arellano

4 joint publications

Eva Ruiz-Hispán

4 joint publications

Víctor Domínguez-Prieto